New search Hide text from Guidelines
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINSThis group comprises all hormonal preparations for systemic use, except:
- Insulins, see A10.
- Anabolic steroids, see A14.
- Catecholamines, see C01C and R03C.
- Sex hormones, see G03.
- Sex hormones used in treatment of neoplastic diseases, see L02.
- Metreleptin used for treatment of complications of leptin deficiency in patients with generalised lipodystrophy is classified in A16AA.
| The DDDs are generally based on the treatment or diagnosis of endocrine disorders. |
H03 THYROID THERAPY
Iodine-therapy products that influence hormonal synthesis or function are classified in H03C - Iodine therapy.
H03A THYROID PREPARATIONS
This group comprises thyroid extracts and synthetic analogues used in the treatment of hypothyrosis.
| The DDDs are based on the treatment of hypothyrosis. |
This group comprises preparations used in the treatment of hyperthyrosis.
| The DDDs are based on the treatment of hyperthyrosis. |
H03C IODINE THERAPY
This group comprises iodine preparations for systemic use.
Last updated: 2024-12-27